Clinical outcomes and health care costs combining metformin with sitagliptin or sulphonylureas or thiazolidinediones in uncontrolled type 2 diabetes patients

OBJECTIVES: To compare clinical outcomes and health care costs across three cohorts of uncontrolled diabetic patients who initiated treatment with one of the following: sulphonylureas (SU), thiazolidinediones (TZD) or sitagliptin (SITA). MATERIALS AND METHODS: We performed a retrospective study base...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Degli Esposti, Luca, Saragoni, Stefania, Buda, Stefano, Degli Esposti, Ezio
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2014
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4211865/
https://ncbi.nlm.nih.gov/pubmed/25364266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S63666
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller